Researchers from Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology’s Program in Speech and Hearing Bioscience and Technology have demonstrated that salicylates, a class of non-steroidal inflammatory drugs (NSAIDs), reduced the proliferation and viability of cultured vestibular schwannoma cells that cause a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus.

The research is described in “Non-steroidal Anti-inflammatory Medications are Cytostatic Against Human Vestibular Schwannomas” online in Translational Research.

Vestibular schwannomas are the most common tumors of the cerebellopontine angle and the fourth most common intracranial tumors.

READ FULL ARTICLE Curated publisher From Medical News Today